Immutep Ltd. (IMMP)
2.86
-0.07
(-2.39%)
USD |
NASDAQ |
Dec 31, 16:00
2.84
-0.02
(-0.70%)
Pre-Market: 20:00
Immutep Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Telix Pharmaceuticals Ltd. | 2.439B |
| Alterity Therapeutics Ltd. | -- |
| Kazia Therapeutics Ltd. | -- |
| Propanc Biopharma, Inc. | 7.264M |
| Mesoblast Ltd. | 2.353B |
Enterprise Value Related Metrics
| Earnings Yield | -9.50% |
| Normalized Earnings Yield | -9.490 |